N-RAP Activators
N-RAP Activators encompass a spectrum of chemical compounds that indirectly promote the functional activity of N-RAP through distinct signaling pathways. For instance, Forskolin, by elevating intracellular cAMP, indirectly supports N-RAP's role in muscle cell adhesion and structure by stimulating PKA, which can phosphorylate substrates that stabilize muscle cell architecture. Similarly, PMA, as a PKC activator, and EGCG, through kinase inhibition, may enhance the structural integrity of muscle cells where N-RAP is critically involved. Sphingosine-1-phosphate and Thapsigargin, by modulating lipid and calcium signaling, respectively, could potentiate N-RAP's role in organizing actin filaments and regulating calcium-dependent processes. On the other hand, PI3K inhibitors like LY294002, by shifting the signaling balance, might indirectly influence N-RAP activity in maintaining muscle cell integrity.
Further enhancing N-RAP's functionality, compounds such as SB203580 and U0126, which target the MAPK pathway, could create a signaling milieu that favors N-RAP's involvement in myocyte stress fiber formation and focal adhesion. Genistein's tyrosine kinase inhibition might also indirectly facilitate N-RAP's engagement in these processes by reducing competitive signaling pathways. Additionally, compounds like A23187 enhance N-RAP activity by elevating intracellular calcium, a crucial element of muscle cell signaling. Staurosporine, despite broadly targeting protein kinases, could paradoxically enhance N-RAP's functional activity by inhibiting kinases that otherwise suppress N-RAP-related pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which can activate Protein Kinase A (PKA). PKA phosphorylation targets may include those involved in the same cellular structures as N-RAP, indirectly enhancing its functional activity related to muscle cell structure and adhesion. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits a range of kinases, which might reduce competitive signaling and indirectly support pathways that upregulate N-RAP activity, particularly in the context of cardiac muscle cells where N-RAP is known to be involved. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a potent activator of Protein Kinase C (PKC), PMA can modulate signaling pathways that intersect with the biological processes N-RAP is involved in, such as sarcomere assembly, potentially enhancing N-RAP's stabilizing role in muscle cells. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
By engaging in sphingolipid signaling, sphingosine-1-phosphate can influence actin dynamics and potentially enhance N-RAP's role in organizing actin filaments within muscle cells. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As an inhibitor of PI3K, LY294002 might shift signaling balance towards pathways that N-RAP is associated with, particularly in the maintenance of the integrity of muscle cells. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels, which can activate calcium-dependent signaling cascades; this may enhance N-RAP function in calcium-dependent processes within muscle cells. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAPK, potentially altering the signaling environment in favor of pathways that involve N-RAP in stress fiber formation and focal adhesion in myocytes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein may allow for the enhancement of N-RAP related pathways by reducing competitive tyrosine kinase signaling, which is significant in cardiomyocyte function and structure. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as an ionophore that increases intracellular calcium levels, which could enhance N-RAP's role in the regulation of calcium-dependent signaling in muscle cells. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Although a broad-spectrum protein kinase inhibitor, Staurosporine might selectively enhance pathways that N-RAP is involved in by inhibiting kinases that negatively regulate muscle cell structure and function. | ||||||